A
Actinium Pharmaceuticals Inc
AMEX:ATNM
Actinium Pharmaceuticals Inc
AMEX:ATNM
Price:
1.11
USD
-4.31%
Market Closed
Market Cap:
$34.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Actinium Pharmaceuticals Inc
AMEX:ATNM
|
US |
|
3i Group PLC
LSE:III
|
UK |
|
W
|
WW Grainger Inc
SWB:GWW
|
US |
|
Jiangsu Phoenix Publishing & Media Corp Ltd
SSE:601928
|
CN |
|
Carnival Corp
NYSE:CCL
|
US |
|
Markel Corp
NYSE:MKL
|
US |
|
Coherent Corp
NYSE:COHR
|
US |
|
Ollie's Bargain Outlet Holdings Inc
NASDAQ:OLLI
|
US |
|
Ryder System Inc
NYSE:R
|
US |
|
S
|
StubHub Holdings Inc
NYSE:STUB
|
US |
|
Hartford Financial Services Group Inc
NYSE:HIG
|
US |
|
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
UK |
|
Henkel AG & Co KGaA
XETRA:HEN
|
DE |
|
SPS Commerce Inc
NASDAQ:SPSC
|
US |
Wall St Price Targets
ATNM Price Targets Summary
Actinium Pharmaceuticals Inc
Actinium Pharmaceuticals Inc
Wall Street analysts forecast ATNM stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ATNM is 5.1 USD with a low forecast of 2.02 USD and a high forecast of 9.45 USD.
Lowest Forecast
Price Target
2.02
USD
82% Upside
Average Forecast
Price Target
5.1
USD
359% Upside
Highest Forecast
Price Target
9.45
USD
751% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ATNM's stock price target?
Price Target
5.1
USD
5.1
USD
According to Wall Street analysts, the average 1-year price target for ATNM is 5.1 USD with a low forecast of 2.02 USD and a high forecast of 9.45 USD.
What is the Revenue forecast for Actinium Pharmaceuticals Inc?
Projected CAGR
196%
196%
The compound annual growth rate for Revenue over the next 8 years is 196%.
